• Computational Antibody Design Enables Dual Mushroom Toxin De

  2026-06-19

  This study introduces a computational chemistry-driven approach to hapten design and monoclonal antibody optimization, resulting in a sensitive dual-target fluorescent immunochromatographic assay for simultaneous detection of amatoxins and phallotoxins in mushrooms. The findings advance rapid, on-site detection and inform future toxicology and food safety workflows.

• Optimizing Synthetic mRNA: ARCA’s Role in Translational Rese

  2026-06-19

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, is transforming the efficiency and safety of synthetic mRNA workflows. This article integrates mechanistic insights, experimental best practices, and strategic advice for translational researchers, with direct links to cutting-edge hiPSC differentiation studies and authoritative product resources.

• EZ Cap™ Cy5 Firefly Luciferase mRNA: Precision Dual-Reporter

  2026-06-18

  Discover how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables high-fidelity mRNA delivery, dual-modality tracking, and advanced translation efficiency analysis. This article uncovers untapped insights from recent lung-targeted delivery research and positions APExBIO’s solution for cutting-edge gene expression studies.

• Promethazine HCl in Advanced Immunometabolism & Host Defense

  2026-06-18

  Explore how Promethazine HCl, a phenothiazine derivative, enables advanced research in immunometabolism and host defense beyond classical histaminergic inhibition. Unique mechanistic insights and practical assay strategies set this article apart.

• Annexin V-FITC/7-AAD Apoptosis Kit: Protocol & QC Essentials

  2026-06-17

  The Annexin V-FITC/7-AAD Apoptosis Kit enables rapid, sensitive discrimination between apoptotic and necrotic cells in established cell viability and cytotoxicity assay workflows. It is optimal for researchers utilizing fluorescence microscopy or flow cytometry, but should not be applied to mechanistic pathway studies or unvalidated sample types.

• CBD Modulates Orofacial Inflammatory Pain via Endocannabinoi

  2026-06-17

  This study demonstrates that cannabidiol (CBD) robustly attenuates both the sensory and affective dimensions of orofacial inflammatory pain in mice. By integrating behavioral, molecular, and neurocircuit analyses, the authors reveal a multidimensional mechanism involving endocannabinoid and serotonergic modulation, highlighting new avenues for translational pain management.

• Chloroquine’s Antiviral Evidence: Lessons for Hepatitis B Re

  2026-06-16

  The reference paper rigorously examines chloroquine's antiviral history, highlighting its inconsistent efficacy across acute and chronic viral infections and underscoring the importance of robust translational models. Its findings emphasize the need for evidence-based evaluation of drug candidates like Entecavir in chronic hepatitis B research.

• Saquinavir in HIV Protease Inhibitor Research: Applied Advan

  2026-06-16

  Saquinavir, a benchmark HIV protease inhibitor, empowers translational drug discovery by bridging high-throughput permeability modeling and robust antiretroviral workflows. This article delivers actionable assay enhancements, protocol parameters, and troubleshooting strategies, rooted in cutting-edge biomimetic chromatography research for both HIV and emerging oncology applications.

• Bismuth Subsalicylate: Beyond GI Research—Membrane & Apoptos

  2026-06-15

  Explore the multifaceted role of Bismuth Subsalicylate in gastrointestinal disorder research and its emerging value in membrane biology and apoptosis detection. This article offers a unique, evidence-grounded perspective for scientists aiming to optimize inflammation and cell death assays.

• KPT330 Enhances Precision of Cas9 Editing via mRNA Export Co

  2026-06-15

  The referenced study demonstrates that KPT330, a selective inhibitor of nuclear export, increases the specificity of CRISPR-Cas9 genome and base editing by modulating Cas9 mRNA export rather than directly inhibiting the Cas9 protein. This mechanistic advance introduces a novel, indirect means to control CRISPR activity and mitigate off-target effects in mammalian cells.

• BFH772 (VEGFR2 inhibitor): Technical Protocols and Workflow

  2026-06-14

  BFH772 (VEGFR2 inhibitor) is a highly selective small molecule designed for precise inhibition of VEGFR2-mediated angiogenesis, making it well-suited for tumor angiogenesis research where receptor specificity is required. It is not appropriate for workflows that need water solubility or broad-spectrum kinase inhibition, and requires careful attention to solvent handling and storage for reliable results.

• IEM 1460: AMPA Receptor Blocker Workflows for Neuroprotectio

  2026-06-13

  IEM 1460 empowers neuroscience research with selective AMPA receptor blockade, enabling high-fidelity studies of excitotoxicity and synaptic modulation. Discover optimized experimental workflows, troubleshooting strategies, and the translational impact of glutamate receptor antagonism in neuroprotection.

• Coumestrol: Molecular Mechanisms and Protocols for RA Resear

  2026-06-12

  Explore Coumestrol's unique role as a phytoestrogen estrogen receptor antagonist and its advanced applications in rheumatoid arthritis research. This article offers deep mechanistic analysis, protocol guidance, and practical insights not found in existing resources.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-12

  The reference study rigorously demonstrates that male and female mice respond differently to chronic angiotensin II infusion, with males showing a markedly greater hypertensive response. These findings highlight the critical influence of sex hormones on hypertension development and underscore the necessity of considering sex as a biological variable in cardiovascular research.

• Antidepressant Effects of Rotigotine in Preclinical Models

  2026-06-11

  This study demonstrates that rotigotine, a dopamine D2/D3 receptor agonist, exerts antidepressant-like effects in multiple validated rodent models of depression. These findings clarify rotigotine's pharmacodynamic profile and suggest its potential utility in addressing comorbid depression in Parkinson's disease research.

451 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page